Latest Articles

Publication Date
Engineered Exosomes Restore miR-508-5p Expression in Uterine Corpus Endometrial Carcinoma and Reduce Tumor Progression and Metastasis by Targeting DLL3 - Frontiers

Engineered Exosomes Restore miR-508-5p Expression in Uterine Corpus Endometrial Carcinoma and Reduce Tumor Progression and Metastasis by Targeting DLL3 Frontiers

Published: Feb. 3, 2025, 2:27 p.m.
Construction of cuproptosis-related genes risk model predicts the prognosis of Uterine Corpus Endometrial Carcinoma - Nature.com

Construction of cuproptosis-related genes risk model predicts the prognosis of Uterine Corpus Endometrial Carcinoma Nature.com

Published: Jan. 17, 2025, 8:46 a.m.
A novel mitochondrial-related risk model for predicting prognosis and immune checkpoint blockade therapy response in uterine corpus endometrial carcinoma - Nature.com

A novel mitochondrial-related risk model for predicting prognosis and immune checkpoint blockade therapy response in uterine corpus endometrial carcinoma Nature.com

Published: Jan. 9, 2025, 7:28 a.m.
A risk prediction model for endometrial hyperplasia/endometrial carcinoma in premenopausal women - Nature.com

A risk prediction model for endometrial hyperplasia/endometrial carcinoma in premenopausal women Nature.com

Published: Jan. 6, 2025, 7:05 p.m.
Bioinformatics approaches to multi-omics analysis of the potential of CDKN2A as a biomarker and therapeutic target for uterine corpus endometrial carcinoma - Nature.com

Bioinformatics approaches to multi-omics analysis of the potential of CDKN2A as a biomarker and therapeutic target for uterine corpus endometrial carcinoma Nature.com

Published: Jan. 6, 2025, 7:50 a.m.
Exploratory Analysis of Radiomics and Pathomics in Uterine Corpus Endometrial Carcinoma - Nature.com

Exploratory Analysis of Radiomics and Pathomics in Uterine Corpus Endometrial Carcinoma Nature.com

Published: Dec. 28, 2024, 3:08 a.m.
TEFM facilitates uterine corpus endometrial carcinoma progression by activating ROS-NFκB pathway - Journal of Translational Medicine

TEFM facilitates uterine corpus endometrial carcinoma progression by activating ROS-NFκB pathway Journal of Translational Medicine

Published: Dec. 27, 2024, 1:02 p.m.
HLA-DMB Correlates With Antitumor Immunity and an Improved Prognosis in Endometrial Carcinoma Tumors - Frontiers

HLA-DMB Correlates With Antitumor Immunity and an Improved Prognosis in Endometrial Carcinoma Tumors Frontiers

Published: Dec. 20, 2024, 4:13 p.m.
MTFR2 promotes endometrial carcinoma cell proliferation and growth via the miR-132-3p /PI3K/Akt signaling pathway - Frontiers

MTFR2 promotes endometrial carcinoma cell proliferation and growth via the miR-132-3p /PI3K/Akt signaling pathway Frontiers

Published: Nov. 25, 2024, 3:55 p.m.
Autophagy Involvement in Non-Neoplastic and Neoplastic Endometrial Pathology: The State of the Art with a Focus on Carcinoma.

Autophagy is a cellular process crucial for maintaining homeostasis by degrading damaged proteins and organelles. It is stimulated in response to stress, recycling nutrients and generating energy for cell survival. …

Published: Nov. 12, 2024, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!